Your browser doesn't support javascript.
loading
Comparative effectiveness between mosunetuzumab monotherapy clinical trial and real-world data in relapsed/refractory follicular lymphoma in third or subsequent lines of systemic therapy.
McGough, Sarah F; Shamas, Natasha; Wang, Jue; Jaber, Mahmoud; Swarup, Binay; Blanchet Zumofen, Marie-Hélène; Lautié, Bertrand; Parreira, Joana; Wei, Michael C; Shewade, Ashwini.
Afiliação
  • McGough SF; Genentech, Inc., South San Francisco, California, USA.
  • Shamas N; Genentech, Inc., South San Francisco, California, USA.
  • Wang J; Genentech, Inc., South San Francisco, California, USA.
  • Jaber M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Swarup B; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Blanchet Zumofen MH; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Lautié B; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Parreira J; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Wei MC; Genentech, Inc., South San Francisco, California, USA.
  • Shewade A; Genentech, Inc., South San Francisco, California, USA.
Leuk Lymphoma ; 64(14): 2269-2278, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37840271

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article